71 results
8-K
EX-99.1
GRTX
Galera Therapeutics Inc
13 May 24
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
7:05am
alternative to provide stockholder value, including a potential development path for avasopasem; the potential safety and efficacy of Galera’s product … and safety laws and regulations; Galera may not be able to enter into any desired strategic alternative or partnership on a timely basis, on acceptable terms
8-K
EX-99.1
GRTX
Galera Therapeutics Inc
28 Mar 24
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
7:06am
safety and efficacy of Galera’s product candidates and their regulatory and clinical development; Galera’s ability to fund its operating expenses … lawsuits; environmental, health and safety laws and regulations; Galera may not be able to enter into any desired strategic alternative or partnership
8-K
EX-99.1
a2f6ewsb
14 Nov 23
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
12:00am
8-K
EX-99.1
s0trjn kne
31 Oct 23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
7:10am
8-K
tpavln6toiqcxswjost0
31 Oct 23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
7:10am
8-K
EX-99.1
cxk64 mhe
14 Aug 23
Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
7:10am
8-K
81g09h ra
10 Aug 23
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
8:00am
8-K
EX-99.1
o9cfa
10 Aug 23
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
8:00am
8-K
EX-99.1
o6w3b9nrvya66
11 May 23
Galera Reports First Quarter 2023 Financial Results and Recent Corporate
7:11am
8-K
EX-99.1
6606rt5d1
12 Dec 22
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
8:00am
8-K
EX-99.1
70urebg5
9 Nov 22
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
7:06am
8-K
EX-99.1
m50rbzs1n2c12sl ybw
26 Oct 22
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
1:41pm
8-K
EX-99.2
5aq kghlx
26 Oct 22
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
1:41pm